364 related articles for article (PubMed ID: 3348823)
1. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis.
Steen VD; Powell DL; Medsger TA
Arthritis Rheum; 1988 Feb; 31(2):196-203. PubMed ID: 3348823
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma: DR antigens, autoantibodies and clinical manifestations.
Alarcón GS; McCarty GA; Lanyon P; Phillips RM; Acton RT; Barger BO
Clin Exp Rheumatol; 1987; 5(4):317-21. PubMed ID: 3326691
[TBL] [Abstract][Full Text] [Related]
4. HLA antigens, autoantibodies and clinical subsets in scleroderma.
Black CM; Welsh KI; Maddison PJ; Jayson MI; Bernstein RM
Br J Rheumatol; 1984 Nov; 23(4):267-71. PubMed ID: 6593111
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.
Steen VD; Ziegler GL; Rodnan GP; Medsger TA
Arthritis Rheum; 1984 Feb; 27(2):125-31. PubMed ID: 6607734
[TBL] [Abstract][Full Text] [Related]
6. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA
Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.
Cepeda EJ; Reveille JD
Curr Opin Rheumatol; 2004 Nov; 16(6):723-32. PubMed ID: 15577611
[TBL] [Abstract][Full Text] [Related]
8. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary manifestation of progressive systemic scleroderma: prognostic value of centromere antibodies and antibodies to Scl-70 nucleoprotein].
Behr J; König G; Meurer M; Krieg T
Pneumologie; 1990 Jun; 44(6):822-5. PubMed ID: 2381889
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil.
Skare TL; Fonseca AE; Luciano AC; Azevedo PM
An Bras Dermatol; 2011; 86(6):1075-81. PubMed ID: 22281893
[TBL] [Abstract][Full Text] [Related]
12. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
13. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
14. Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).
Reveille JD; Owerbach D; Goldstein R; Moreda R; Isern RA; Arnett FC
J Clin Invest; 1992 Apr; 89(4):1208-13. PubMed ID: 1556182
[TBL] [Abstract][Full Text] [Related]
15. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?
Janardana R; Nair AM; Surin AK; Prakash JAJ; Gowri M; Danda D
Clin Rheumatol; 2019 Nov; 38(11):3179-3187. PubMed ID: 31309339
[TBL] [Abstract][Full Text] [Related]
16. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
[TBL] [Abstract][Full Text] [Related]
17. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
Coelho Horimoto AM; da Costa IP
Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
[TBL] [Abstract][Full Text] [Related]
18. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.
Sujau I; Ng CT; Sthaneshwar P; Sockalingam S; Cheah TE; Yahya F; Jasmin R
Int J Rheum Dis; 2015 May; 18(4):459-65. PubMed ID: 24618222
[TBL] [Abstract][Full Text] [Related]
19. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.
Vlachoyiannopoulos PG; Dafni UG; Pakas I; Spyropoulou-Vlachou M; Stavropoulos-Giokas C; Moutsopoulos HM
Ann Rheum Dis; 2000 May; 59(5):359-67. PubMed ID: 10784518
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetic associations of scleroderma-related antinuclear antibodies.
Genth E; Mierau R; Genetzky P; von Mühlen CA; Kaufmann S; von Wilmowsky H; Meurer M; Krieg T; Pollmann HJ; Hartl PW
Arthritis Rheum; 1990 May; 33(5):657-65. PubMed ID: 2346521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]